Contact this trialFirst, we need to learn more about you.
Glucagon-like peptide-1 (GLP-1) receptor agonist
Semaglutide for Prediabetes Post-GDM
Recruiting2 awardsPhase 4
Baton Rouge, Louisiana
This trial is testing semaglutide, a medication that helps control blood sugar, in women who had gestational diabetes and now have high blood sugar levels. These women are at risk of developing type 2 diabetes. The goal is to see if semaglutide can help them return to normal blood sugar levels and reduce their future diabetes risk. Semaglutide is developed for the treatment of type 2 diabetes and has shown benefits in controlling blood sugar and weight loss.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service